(Q75438015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

title

The economic burden of supportive care of cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

author name string

Linda S Elting

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Ya-Chen Tina Shih

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

publication date

7 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

18 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

219-226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767748%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00520-003-0513-1

18 November 2019

exact match

0 references

cites work

Platelet transfusions: utilization and associated costs in a tertiary care hospital

1 reference

12 December 2020

Complications and Costs After High-Risk Surgery: Where Should We Focus Quality Improvement Initiatives?

1 reference

12 December 2020

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema

1 reference

12 December 2020

An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada

1 reference

12 December 2020

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncolo

1 reference

12 December 2020

Management paradigms for posterior epistaxis: A comparison of costs and complications

1 reference

12 December 2020

What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis

1 reference

12 December 2020

Costs of Treating and Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

1 reference

12 December 2020

Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

1 reference

12 December 2020

The economic burden of COPD.

1 reference

12 December 2020

An economic overview of chronic obstructive pulmonary disease

1 reference

12 December 2020

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

1 reference

12 December 2020

Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications

1 reference

12 December 2020

Inflation spurs health spending in 2000

1 reference

12 December 2020

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

1 reference

12 December 2020

Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.

1 reference

12 December 2020

Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer

1 reference

12 December 2020

Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspective

1 reference

12 December 2020

Applying epidemiology-based outcomes research to clinical decision-making. A hypothetical model of biotechnology therapy in gram-negative sepsis

1 reference

12 December 2020

Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.

1 reference

12 December 2020

A pharmacoeconomic model to evaluate antibiotic costs.

1 reference

12 December 2020

Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany.

1 reference

12 December 2020

A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain

1 reference

12 December 2020

Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia

1 reference

12 December 2020

Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

1 reference

12 December 2020

Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery

1 reference

12 December 2020

The costs of treating febrile neutropenia in six U.K. Hospitals

1 reference

12 December 2020

Current trends in the use of pharmacoeconomics and outcomes research in europe

1 reference

12 December 2020

Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.

1 reference

12 December 2020

Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors

1 reference

12 December 2020

Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries

1 reference

12 December 2020

Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.

1 reference

12 December 2020

Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial

1 reference

12 December 2020

Resource utilization for acute lower gastrointestinal hemorrhage: the Ontario GI bleed study

1 reference

12 December 2020

The costs of treating febrile neutropenia in patients with malignant blood disorders

1 reference

12 December 2020

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia

1 reference

12 December 2020

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia

1 reference

12 December 2020

Severity of illness, outcomes, and resource use in elderly cancer patients with deep venous thrombosis

1 reference

12 December 2020

Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995

1 reference

12 December 2020

The economic impact of infections. An analysis of hospital costs and charges in surgical patients with cancer

1 reference

12 December 2020

Quality of Life and Economic Considerations in the Management of Prostate Cancer

1 reference

12 December 2020

Blood transfusion costs: a multicenter study.

1 reference

12 December 2020

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

1 reference

12 December 2020

Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment

1 reference

12 December 2020

Resource utilization and cost of episodes of febrile neutropenia in children with acute leukemias and lymphomas

1 reference

12 December 2020

The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer

1 reference

12 December 2020

Mucositis in head and neck cancer: economic and quality-of-life outcomes.

1 reference

12 December 2020

Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices

1 reference

12 December 2020

Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy

1 reference

12 December 2020

Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy

1 reference

12 December 2020

Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer. A cost-effectiveness analysis

1 reference

12 December 2020